Evaluating Carotid intima media thickness (CIMT) of patients with Non - Alcoholic fatty liver disease (NAFLD) as a risk factor for atherosclerosis and correlation with metabolic syndrome

Raghuram K; Lavanya; Ram Kumar M; Jagadeesan M; Prasanna Karthik S; Kannan R; Gowrishankar A; Mageshkumar S

Raghuram K ⁽¹⁾ , Lavanya ⁽²⁾ , Ram Kumar M ⁽³⁾ , Jagadeesan M ⁽⁴⁾ , Prasanna Karthik S ⁽⁵⁾ , Kannan R ⁽⁶⁾ , Gowrishankar A ⁽⁷⁾ , Mageshkumar S ⁽⁸⁾

(1) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India ,

(2) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India ,

(3) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India ,

(4) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India ,

(5) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India ,

(6) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India ,

(7) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India ,

(8) Department of General Medicine, Saveetha Medical College and Hospitals, Thandalam, Chennai – 602105, Tamil Nadu, India, India

Issue
Vol. 12 No. 3 (2021): Volume 12 Issue 3

Keywords:

Fatty Liver, Carotid Arteries, Atherosclerosis, Diabetes mellitus

PDF LaTeX HTML ePUB

Abstract

This study aimed to evaluate the effect of NAFLD on CIMT as a risk factor for atherosclerosis. The incidence of non-alcoholic fatty liver disease (NAFLD) is escalating worldwide due to mount of obesity and diabetes mellitus (DM) prevalence. Non-invasive appraisal of carotid intima-media thickness (CIMT) by high-resolution carotid B-mode ultrasonography is broadly used for determining atherosclerosis. In this case-control setting, 151 subjects were categorized in three groups: group I counting 49 patients with NAFLD and DM; group II counting 50 non-diabetic NAFLD patients; and the control with 52 normal subjects as group III. The right and left CIMTs and its maximum reading (CIMT max) were deliberated by a skilled sonographist blind to the groups. The sonographic grading of the NAFLD was dogged in groups I and II. Median CIMT max was extensively higher in group I comparing with group II and control group (p<0.001). This disparity between group I and group II were not significant after adjusting for age and history of hypertension and hyperlipidemia (p=0.089). After scheming the confounders, there was a statistically significant between-group I and group II with the control group (p<0.05). There was no significant disparity in median maximal thickness of intima-media in the carotid of group I compare to group II in patients with and without prominent liver enzymes (in both groups, 0.6 mm, p= 0.402). Based on our findings, there is a significant relationship between the presence of NAFLD and atherosclerosis. This association was independent to the Diabetes mellitus presence. The grade of NAFLD and elevated liver function tests had no effect on the severity of atherosclerosis.

Full text article

Generated from XML file

References

Adams, L. A., Lindor, K. D. 2007. Nonalcoholic Fatty Liver Disease. Annals of Epidemiology, 17(11):863–869.

Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., Bellentani, S. 2005. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology, 42(1):44–52.

Bellentani, S., Saccoccio, G., et al. 2000. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy. Annals of Internal Medicine, 132(2):112–117.

Chouhan, M., Kansal, A., Trikha, S., Gupta, M. 2017. Mayank Gupta To study the carotid intima media thickness in patients of fatty liver disease. International Journal of Advances in Medicine, 4(5):1282–1287.

Clark, J. M., Brancati, F. L., Diehl, A. M. 2003. The prevalence and etiology of elevated aminotransferase levels in the United States. The American Journal of Gastroenterology, 98(5):960–967.

Das, S. K., Mukherjee, S., Vasudevan, D. M. 2006. Non-alcoholic Fatty liver disease: an under-recognized cause with emerging importance. CurrSci, 90(5):659–665.

Farrell, G. C., Larter, C. Z. 2006. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology, 43(2 Supple 1):S99–S112.

Harrison, S. A., Kadakia, S., Schenker, S. 2002. Nonalcohololic steatohepatitis: what we know in the New Millennium. Am J Gastroenterol, 97(11):2714–2724.

Hubscher, S. G. 2006. Histological assessment of non-alcoholic fatty liver disease. Histopathology, 49(5):450–465.

Kotronen, A., Yki-Järvinen, H. 2008. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol, 28(1):27–38.

Lidofsky, S. D. 2008. Nonalcoholic fatty liver disease: Diagnosis and relation to metabolic syndrome and approach to treatment. Current Diabetes Reports, 8(1):25–30.

Lundqvist, G., Flodin, U., Axelson, O. 1999. A case-control study of fatty liver disease and organic solvent exposure. American Journal of Industrial Medicine, 35(2):132–136.

Nahandi, M. Z., Khoshbaten, M. 2014. Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. Gastroenterol Hepatol Bed Bench, 7(1):55–62.

Paschos, P., Paletas, K. 2009. Non-alcoholic fatty liver disease and metabolic syndrome. Hippokratia, 13(1):9–19.

Setji, T. L., Holland, N. D., Sanders, L. L., Pereira, K. C., Diehl, A. M., Brown, A. J. 2006. Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism, 91(5):1741–1747.

Targher, G., Bertolini, L., Padovani, R., Zenari, L., Zoppini, G., Falezza, G. 2004. Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men: Role of visceral fat accumulation. Diabetes Care, 27(10):2498–2500.